Good MorningThe market was largely unmoved by the FOMC on Wednesday after the committee delivered a message that was little more than expected. The FOMC made note of the COVID-vaccines and their impact on the recovery. The committee also noted that labor markets were strengthening although there was still weakness in some areas of the economy. In regards to inflation, committee chairman Jerome Powell says the recent increases in prices are likely to continue although inflation will be transitory.
The after-hours action was a little different. Reports from Facebook, Ford, Ebay, and Apple grabbed the market’s attention and had shares moving. Reports were equally strong and point to an accelerating economic rebound but not all shares moved in the same direction. Action on Thursday could be more of the same sluggish sideways movement as the market digests the latest round of news.
Featured: Tired of losing money in volatile markets? (Trader News Media) 
|
Stocks | | | Large-cap stocks Rio Tinto (NYSE: RIO), Goldman Sachs (NYSE: GS) and PayPal (NASDAQ: PYPL) are all forming potentially constructive price consolidations, and may be nearing buy points.
The old advice to “buy low and sell high” applies to stocks that are consolidating.
But t... Read the Full Story |
|
From Our PartnersThey called the 2020 crash 45 days early. Nobody expects what they're predicting now... | | | | Learn more here! |
|
Politics | | | World shares advanced Thursday ahead of the release of U.S. economic growth data and following a speech by President Joe Biden outlining ambitious plans for beefing up early education and other family oriented policies.
London's FTSE 100 jumped 0.7% to 7,013.40. In Paris, the CAC40 c... Read the Full Story |
|
Markets | | | BMRN stock is consolidating on light volume prior to earnings. The company is projected to report earnings and revenue that are lower on a year-over-year basis. With a potential upside of over 46%, that could make BioMarin an attractive buying option. Read the Full Story |
|
From Our PartnersThe U.S. dollar is in free fall and many analysts are predicting the crash will continue under President Biden. Banks across the country are already preparing.
The agency that regulates all banks in the U.S. issued this new rule that will change everything. | | | | If you have money in the bank… |
|
Markets | | | Philip Morris International (NYSE: PM) broke out of a two-year base in February, and the tobacco giant’s shares have shown no signs of slowing down. In the two-and-a-half months since the breakout, PM shares have moved around 10% higher. Read the Full Story |
|
Markets | | | One of the biggest pandemic winners last year was Shopify (NYSE:SHOP), a company that offers a software platform for retailers that helps them set up their stores online. The stock rallied over 179% in 2020 thanks to broad shifts in the retail landscape and unprecedented demand for e-commerce. Many ... Read the Full Story |
|
From Our PartnersThe Wall Street Journal reports new treatment is "transforming medicine."
Bill Gates writes that it could "help humanity."
Ark Investments think it could be a "$2 trillion market."
And one small company owns the patent on it. | | This unknown biotech's stock is set to surge 46,751% >>> |
|
Politics | | | NAIROBI, Kenya — Africa’s top public health official says the continent is “watching with total disbelief” what is happening in India as it struggles with a devastating resurgence in COVID-19 cases.
Africa Centers for Disease Control and Prevention Director John Nkengasong warned tha... Read the Full Story |
|
Politics | | | LISBON, Portugal -- The head of the World Health Organization says more than 1 billion doses of COVID-19 vaccines have been administered globally but 82% of them were given in high- and upper-middle-income countries.
WHO Director-General Tedros Adhanom Ghebreyesus says just 0.3% of al... Read the Full Story |
|
Politics | | | Germany’s top court has ruled that the government has to set clear goals for reducing greenhouse gas emissions after 2030, arguing that current legislation doesn’t go far enough in curbing climate change Read the Full Story |
|
Politics | | | China’s population grew last year, the government said Thursday, following a report that a census might have found a surprise decline, possibly adding to downward pressure on economic growth.
The National Bureau of Statistics gave no details in its one-sentence statement and said the ... Read the Full Story |
|
Markets | | |
A year removed from its historic plunge into the $50's, fast-food restaurant operator Yum! Brands (NYSE:YUM) is approaching its record intraday high of $119.72 set back in August 2018.
The remarkable turnaround is a credit to the company's ability to adapt to the pandemic economy along with marke... Read the Full Story |
|
The Early Bird Stock Of The Day Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
